The Impact of Semantics in Medicines Regulation.

Words can have inherently multiple meanings; therefore, semantics can directly impact policies and behaviours. In regulatory practice, semantics refers to the specific, actionable meaning behind terminology, and attention to semantics can help ensure that legal frameworks are interpreted accurately. Refining semantics is not a purely theoretical exercise, but a subtle yet powerful element that has the potential to make the regulatory system more efficient in setting priorities and more reliable in meeting societal expectations and needs. When their intended purpose does not align with their true meaning, labels widely used in pharmaceutical regulation such as "breakthrough," "orphans," or "unmet medical need" risks undermining the clarity and precision essential to a sound regulatory framework. In addition, differences in definitions, scopes, eligibility criteria, and incentives can obstruct the efficient convergence of efforts in drug development and access. As pharmaceutical investments and clinical research increasingly transcend borders, the adoption of consistent terminology and regulatory definitions becomes crucial. This alignment can enhance cooperation among investors, governments, regulators, researchers, health care practitioners, and patients.